Abilify Oral to LAI Dosing Conversion
For adults with schizophrenia stable on oral aripiprazole for at least 14 days, initiate Abilify Maintena 400 mg monthly using either a 1-day or 14-day initiation regimen, with the 1-day regimen offering the advantage of eliminating the need for prolonged oral supplementation. 1
Two FDA-Approved Initiation Options
1-Day Initiation (Preferred for Convenience)
- Day 1: Administer two separate 400 mg IM injections of Abilify Maintena in different injection sites (deltoid or gluteal—do not inject both in the same muscle) plus one 20 mg oral aripiprazole dose 1
- No additional oral supplementation required after Day 1
- Achieves therapeutic aripiprazole levels rapidly 2
- Recent evidence suggests this regimen maintains serum levels within therapeutic window without peaks above it, potentially offering better safety profile 2
14-Day Initiation (Traditional Method)
- Day 1: Administer one 400 mg IM injection (deltoid or gluteal)
- Days 1-14: Continue oral aripiprazole 10-20 mg daily for 14 consecutive days 1
- Alternative: If switching from another oral antipsychotic (and patient tolerates aripiprazole), continue the current oral antipsychotic for 14 days instead 1
Key Dosing Details
Standard maintenance dose: 400 mg IM monthly (no sooner than 26 days after previous injection) 1
Dose reduction option: May reduce to 300 mg monthly if adverse reactions occur with 400 mg 1
Monthly dosing schedule: Administer every 4 weeks; over 90% of patients tolerate the 400 mg dose without requiring adjustment 3
Critical Tolerability Requirement
Before initiating LAI: Establish tolerability with oral aripiprazole first. Due to the 75-hour half-life of aripiprazole (94 hours for active metabolite dehydro-aripiprazole), allow up to 2 weeks to fully assess tolerability 1. This is non-negotiable for aripiprazole-naïve patients.
Switching from Other Oral Antipsychotics
When transitioning from a different oral antipsychotic to Abilify Maintena:
- Cross-titrate over >1 to 4 weeks (not ≤1 week) 3
- Gradually taper prior antipsychotic while titrating up oral aripiprazole to target 10-30 mg/day
- This longer cross-titration period significantly reduces discontinuation due to adverse events (2.7% vs 10.4% with ≤1 week) 3
- Once stabilized on oral aripiprazole, proceed with either initiation regimen
Dose Adjustments for Drug Interactions
CYP2D6 poor metabolizers: Start with 300 mg monthly (not 400 mg) 1
Strong CYP2D6 or CYP3A4 inhibitors: Reduce to 300 mg monthly 1
Both CYP2D6 AND CYP3A4 inhibitors: Avoid use with 1-day initiation; use 200 mg with 14-day initiation 1
CYP3A4 inducers: Avoid concomitant use for >14 days (reduces aripiprazole levels below effective range) 1
Missed Dose Management
If 2nd or 3rd dose missed:
- <5 weeks since last injection: Give dose as soon as possible
- ≥5 weeks: Restart with full initiation regimen 1
If 4th or subsequent dose missed:
- <6 weeks since last injection: Give dose as soon as possible
- ≥6 weeks: Restart with full initiation regimen 1
Clinical Pearls
The 1-day initiation regimen is increasingly favored because it eliminates the burden of 14 days of oral supplementation, which improves early adherence and reduces complexity 2. Pharmacokinetic data demonstrate that median aripiprazole concentrations reach therapeutic levels within 7 days of initiating the 400 mg dose 3, supporting both regimens' efficacy. The choice between regimens should consider patient preference, ability to adhere to 14 days of oral medication, and clinical setting logistics.